Lina C Teng

This inventor holds 7 USPTO granted patents. Top assignees: A. H. Robins Company, Incorporated, Philip Morris Inc.. Active years: 1977-1991.

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 84(Granted Patents)

Company Filing History:

4 out of 218

A. H. Robins Company, Incorporated

Years Active: 1977-1991

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5070087 - Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) (1991-12-03),

2. 4722834 - Method of using (1988-02-02),

3. 4571393 - 3-Phenoxy-1-azetidinecarboxamides (1986-02-18),

4. 4505907 - N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides (1985-03-19),

5. 4178458 - Smoking composition (1979-12-11),

6. 4141906 - Smoking composition and compounds therefor (1979-02-27),

7. 4036237 - Smoking composition (1977-07-19),

Title: The Innovative Journey of Inventor Lina C Teng

Introduction

Lina C Teng is a prominent inventor based in Richmond, VA. She has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. Her inventive work focuses on methods of treating various medical conditions, particularly those related to cardiac dysfunction and emesis.

Latest Patents

Lina's latest patents showcase her profound expertise in pharmacological compounds and treatment methods. One of her notable inventions includes an innovative method for treating cardiac dysfunction using aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) compounds. This method is defined by a complex formula that outlines the specific chemical structures involved. Additionally, she has developed a method for controlling emesis caused by anticancer drugs, utilizing 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamide-N-oxides, again highlighting her focus on pharmaceutical advancements.

Career Highlights

Throughout her career, Lina has worked with well-respected companies in the industry, including A.H. Robins Company and Philip Morris Inc. Her experience in these organizations has contributed significantly to her understanding and development of effective pharmaceutical solutions.

Collaborations

Lina C Teng has collaborated with fellow professionals such as David A Walsh and James R Shanklin, Jr. These partnerships have allowed her to combine her innovative ideas with the expertise of others, enhancing her inventions and broadening their impact.

Conclusion

With seven patents to her name, Lina C Teng exemplifies the spirit of innovation in the pharmaceutical industry. Her commitment to developing novel treatment methods is evident in her groundbreaking inventions, which address critical health issues. As a leading female inventor, she continues to inspire others in the field with her contributions and collaborative efforts.